In conclusion, our multi-omic study of metastatic melanoma demonstrates that pretreatment hypoalbuminemia –together with IFN-γ, TMB, and serum LDH– is a strong and independent determinants of survival among ICI-treated patients with this disease. The gene discussed is IFNG; the disease is metastatic melanoma.